The main goal of the MSCA project eRaDicate, in which TG serves as an industrial partner, is to develop new therapies targeting cancer stem cell (CSC)-driven relapse and metastasis. In this webinar, Dr. Martin Schepelmann, Project Coordinator, presents the project milestones, and Dr. Cesar Cobaleda introduces key concepts related to CSCs and their role in cancer development.

Non-small cell lung cancer (NSCLC) is a challenging disease, accounting for approximately 85% of all lung cancer cases.

TissueGnostics will be at the ASI 2025 meeting, 1–5 December in Perth, Australia. Join one of the region’s largest immunology events and meet our team to discuss your imaging needs.

Tissue slide scanners combine whole-slide imaging, multispectral analysis, and AI-driven software to deliver quantitative, context-rich insights into cells, tissues, and microenvironments, advancing biomedical research.

Dr. Diana Mechtcheriakova, Medical University of Vienna, presents research on lymphoid structures in systemic immunity and anti-cancer responses, with applications in colorectal cancer.

This webinar explores how tissue cytometry enables investigation of fatty liver disease, providing insights into liver pathology and immune interactions.

Image-based cytometry is transforming tissue analysis by combining microscopy with flow cytometry features. It enables rapid, automated characterization of cells in their native environment, advancing pathology, oncology, and precision medicine with AI integration.

Characterizing the tissue microenvironment reveals how cells and structures interact in health and disease. This blog highlights its role in cancer research and how TissueGnostics solutions enable advanced imaging and quantitative analysis.